Cargando…
Targeting of Androgen Receptor Expression by Andro-miRs as Novel Adjunctive Therapeutics in Prostate Cancer
Prostate cancer begins as an androgen-responsive disease. However, subsequent accumulation of multiple sequential genetic and epigenetic alterations transforms the disease into an aggressive, castration-resistant prostate cancer (CRPC). The monoallelic Androgen Receptor (AR) is associated with the o...
Autores principales: | Ebron, Jey Sabith, Weyman, Crystal M., Shukla, Girish C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751888/ https://www.ncbi.nlm.nih.gov/pubmed/26877888 http://dx.doi.org/10.4236/jct.2013.44A006 |
Ejemplares similares
-
Housekeeping Gene Selection Advisory: Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) and β-Actin Are Targets of miR-644a
por: Sikand, Kavleen, et al.
Publicado: (2012) -
Androgen-Regulated microRNAs (AndroMiRs) as Novel Players in Adipogenesis
por: Jansen, Julia, et al.
Publicado: (2019) -
Aging and calorie restriction regulate the expression of miR-125a-5p and its target genes Stat3, Casp2 and Stard13
por: Makwana, Kuldeep, et al.
Publicado: (2017) -
miR-377-dependent BCL-xL regulation drives chemotherapeutic resistance in B-cell lymphoid malignancies
por: Al-harbi, Sayer, et al.
Publicado: (2015) -
The androgen receptor messenger RNA: what do we know?
por: Likos, Eviania, et al.
Publicado: (2022)